Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Gains from Investment Securities (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Gains from Investment Securities readings, the most recent being -$15000.0 for Q4 2023.

  • On a quarterly basis, Gains from Investment Securities changed N/A to -$15000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $2000.0, a 105.13% increase, with the full-year FY2025 number at $170000.0, up 5566.67% from a year prior.
  • Gains from Investment Securities hit -$15000.0 in Q4 2023 for Elicio Therapeutics, down from -$6000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.3 million in Q4 2020 to a low of -$733000.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 4 years was -$6000.0 (2023), compared with a mean of $704454.5.
  • Biggest five-year swings in Gains from Investment Securities: crashed 140.0% in 2021 and later tumbled 101.11% in 2022.
  • Elicio Therapeutics' Gains from Investment Securities stood at $4.3 million in 2020, then plummeted by 116.99% to -$733000.0 in 2021, then skyrocketed by 94.68% to -$39000.0 in 2022, then skyrocketed by 61.54% to -$15000.0 in 2023.
  • The last three reported values for Gains from Investment Securities were -$15000.0 (Q4 2023), -$6000.0 (Q3 2023), and $23000.0 (Q2 2023) per Business Quant data.